Salivary gland cancer: ESMO-European Reference Network on Rare Adult Solid Cancers (EURACAN) Clinical Practice Guideline for diagnosis, treatment and follow-up.
(2022) ESMO Open — Vol. 7, n° 6, p. 100602 [1-16] (2022)
Files
2022_van_Herpen_ESMO_Open.pdf
Open Access - Adobe PDF
- 607.86 KB
Details
- Authors
- Abstract
- • This ESMO–EURACAN Clinical Practice Guideline provides key recommendations for managing salivary gland cancer. • The guideline covers clinical and pathological diagnosis, staging and risk assessment, treatment and follow-up. • Treatment algorithms for parotid, submandibular, sublingual and minor salivary gland cancer are provided. • The author group encompasses a multidisciplinary group of experts from different institutions and countries in Europe. • Recommendations are based on available scientific data and the authors’ collective expert opinion.
- Affiliations
Citations
van Herpen, C., Vander Poorten, V., Skalova, A., Terhaard, C., Maroldi, R., van Engen, A., Baujat, B., Locati, L. D., Jensen, A. D., Smeele, L., Hardillo, J., Martineau, V. C., Trama, A., Kinloch, E., Even, C., & Machiels, J.-P. (2022). Salivary gland cancer: ESMO-European Reference Network on Rare Adult Solid Cancers (EURACAN) Clinical Practice Guideline for diagnosis, treatment and follow-up. ESMO Open, 7(6), 100602 [1-16]. https://doi.org/10.1016/j.esmoop.2022.100602 (Original work published 2022)